Researchers from South Ural State University and also N.D. Zelinsky Institute of chemistry, Russian Academy of Sciences are learning poly sulphur-nitrogen heterocycles – organic compounds that have antiviral properties and might be applied for the treatment of AIDS.
In 2015, South Ural State University and also N.D. Zelinsky Institute of chemistry established a laboratory for the synthesis of original poly sulphur-nitrogen heterocycles and looking for new compounds with high and varied biological activity.
It is price noting that this mechanism of action in antiviral medications has not been ascertained before. Throughout their analysis, medications were found among the studied compounds that have each high antiviral activity and low toxicity for normal cells. The invention of this mechanism allowed the researchers to open up a replacement category of heterocyclic poly sulphur-nitrogen compounds which will be used as antiviral medications, further because of the chance to use these medications for varied infectious agent diseases with an analogous mechanism of action.
At this point, the researchers are looking for the optimum structures (with the best price on the therapeutic index) for every disease type. The importance of the obtained results is that any given medication may be used for various kinds of diseases (cancer, HIV, and more), which makes their development additional attention-grabbing in a very sensible sense. Analysis of the mechanism of previously synthesized compounds is going to be continued to treat alternative diseases with similar mechanisms of action.
The most promising space of analysis to be the anti-cancer activity of this compound category. However, unexpectedly, it became clear to the United States of America that this sort of compound may also have high and selective activity against the feline immunological disorder virus, that is the nearest analog to HIV.